Table 2.

Patient descriptions

ID	Age	MMSE or HDS-R score	Onset (years prior to the study)	Functional autonomy	How did the patient learn about BT and make a decision?
A	45–49	MMSE = 24	5	Could go out with a cane and a lower extremity orthosis.	BT was introduced by the primary physician.
					Patient selected BT injection to enhance gait stability and improve upper limb activity.
B	55–59	MMSE = 29	10	Could go out with a cane and a lower extremity orthosis.	BT was introduced by the primary physician.
					Patient selected BT injection to enhance gait stability and improve upper limb activity.
C	60–64	HDS-R = 26	4	Could go out.	BT recommended for a tingling sensation in the foot.
					Patient did not select BT injection owing to the possibility of convulsions.
D	60–64	MMSE = 28	8	Could go out with a cane and a lower extremity orthosis under supervision.	Patient was looking for better treatment options and obtained information about BT.
					Selected BT injection to enhance gait stability and improve upper limb activity.
E	60–64	HDS-R = 26	9	Could go out with a cane and a lower extremity orthosis.	Patient heard about BT from patients who had received BT and healthcare professionals. Selected BT injection to enhance gait stability.
F	70–74	MMSE = 26	6	Could go out with a cane and a lower extremity orthosis under supervision.	BT recommended by healthcare professionals and family members.
					Selected BT injection to enhance gait stability and improve upper limb activity.

BT Botulinum toxin, MMSE Mini-Mental State Examination, HDS-R Revised Hasegawa’s Dementia Scale